Free Trial

CoreCap Advisors LLC Has $1.80 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

CoreCap Advisors LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 127.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,553 shares of the healthcare conglomerate's stock after buying an additional 1,991 shares during the period. CoreCap Advisors LLC's holdings in UnitedHealth Group were worth $1,797,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth $28,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. Finally, Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Morgan Stanley cut their target price on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Hsbc Global Res lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 22nd. Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Barclays reduced their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $596.86.

Read Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Down 1.3 %

Shares of UNH traded down $4.83 during mid-day trading on Friday, hitting $380.72. 8,371,190 shares of the company's stock were exchanged, compared to its average volume of 4,716,091. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $378.54 and a twelve month high of $630.73. The firm has a fifty day moving average of $488.01 and a two-hundred day moving average of $522.60. The stock has a market cap of $346.54 billion, a price-to-earnings ratio of 24.56, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the firm earned $6.91 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 2.21%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines